Share This Article:

Determination of Candesartan and Hydrochlorothiazide in Human Plasma by HPLC Coupled with Mass Spectrometry

Abstract Full-Text HTML Download Download as PDF (Size:1141KB) PP. 25-32
DOI: 10.4236/ijamsc.2014.22003    3,732 Downloads   4,831 Views   Citations

ABSTRACT

Quantitative determination of hydrochlorothiazide (HCTZ) and candesartan (CDS) in human plasma in volunteers was performed using a sensitive, selective and specific LC-MS method which has been developed and validated before the study. The study was performed by means of a liquid chromatograph Shimadzu Prominence equipped with a mass spectrometer LCMS-2020. Analytical column PerfectBond ODS-HD HPLC-column 5 μm 250 × 3.0 mm with a pre-column cartridge PerfectBond ODS-HD 5 μm 10 × 3.0 mm, double source of ionization for LCMS-2020 (electrospray (ESI) and chemical (APCI)) and software LabSol LCMS V5 LCMS2020 systempack were used. The low limit of the quantitative determination for HCTZ and CDS made up 10 ng/ml. m/z for CDS 441.20—positive scan, m/z for HCTZ 295.90—negative scan. The method has been applied to a pharmacokinetic study of 12.5 mg HCTZ and 16 mg CDS tablet in healthy volunteers.

Cite this paper

Brushinina, O. , Gurto, R. , Timofeev, M. , Frelikh, G. , Slepichev, V. , Yanovskaya, E. , Polomeeva, N. , Zyuz’kova, Y. and Udut, V. (2014) Determination of Candesartan and Hydrochlorothiazide in Human Plasma by HPLC Coupled with Mass Spectrometry. International Journal of Analytical Mass Spectrometry and Chromatography, 2, 25-32. doi: 10.4236/ijamsc.2014.22003.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] Gupta, A.K., Arshad, S. and Poulter, N.R. (2010) Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents. Hypertension, 55, 399-407.
[2] Hernández-Hernández, R., Sosa-Canache, B., Velasco, M., Armas-Hernández, M.J., Armas-Padilla, M.C. and Cam- marata, R. (2002) Angiotensin II Receptor Antagonists Role in Arterial Hypertension. Journal of Human Hypertension, 16, 93-99. http://dx.doi.org/10.1038/sj.jhh.1001352
[3] Unger, T. (2003) Blood Pressure Lowering and Rennin Angiotensin System Blockade. Hypertension, 21, 3-7. http://dx.doi.org/10.1097/00004872-200307006-00002
[4] Vetuschi, C., Giannandrea, A., Carlucci, G. and Mazzeo, P. (2005) Determination of Hydrochlorothiazide and Irbesar- tan in Pharmaceuticals by Fourth-Order UV Derivative Spectrophotometry. Farmaco, 60, 665-670. http://dx.doi.org/10.1016/j.farmac.2005.04.013
[5] Tu, J.H., Zhu, Y.B. and Xiao, D.W. (2008) Determination of Candesartan in Human Plasma by HPLC with Fluores- cence. China Pharmaceuticals, 5, 48-49.
[6] Singh, B., Lokhandae, R.S., Dwivedi, A., Sharma, S. and Dubey, N. (2014) Improved Simultaneous Quantitation of Candesartan and Hydrochlorthiazide in Human Plasma by UPLC-MS/MS and Its Application in Bioequivalence Stu- dies. Journal of Pharmaceutical Analysis, 4, 144-152.
[7] Gao, F., Zhang, M.L., Cui, X.Y., Wang, Z.H., Sun, Y.T. and Gu, J.K. (2010) Simultaneous Quantitation of Hydroch- lorothiazide and Metoprolol in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 52, 149-154. http://dx.doi.org/10.1016/j.jpba.2009.12.012
[8] Ramakrishna, N.V., Vishwottam, K.N. and Manoj, S. (2005) Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method for Quantification of Hydrochlorothiazide in Human Plasma. Biomedical Chromatography, 19, 751- 760. http://dx.doi.org/10.1002/bmc.510
[9] Zendelovska, D., Stafilov, T. and Milosevski, P. (2004) Development of Solid-Phase Extraction Method and Its Appli- cation for Determination of Hydrochlorothiazide in Human Plasma Using HPLC. Biomedical Chromatography, 18, 71-76. http://dx.doi.org/10.1002/bmc.293

  
comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.